Global Inequality in Type 1 Diabetes: a Comparison of Switzerland and Low-and Middle-Income Countries.
Access
Insulin
Type 1 diabetes
Journal
Pediatric endocrinology reviews : PER
ISSN: 1565-4753
Titre abrégé: Pediatr Endocrinol Rev
Pays: Israel
ID NLM: 101202124
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
entrez:
26
3
2020
pubmed:
26
3
2020
medline:
6
5
2020
Statut:
ppublish
Résumé
Globally it is estimated that over 1 million children and adolescents have Type 1 diabetes with large variations in incidence between different contexts. Health systems need to provide a variety of elements to ensure appropriate diabetes care, such as service delivery; healthcare workforce; information; medical products and technologies; financing and leadership and governance. Describing these elements between Geneva, Switzerland, a high-income country with high spending on healthcare and a large density of doctors, and low- and middle-income countries this article aims to highlight the global inequality of diabetes care. Type 1 diabetes can serve as a litmus as we move towards the centenary of the discovery of insulin and beyond as there is a need for a global movement to ensure that innovation in the management of diabetes benefits the whole diabetes community and not just a select few.
Identifiants
pubmed: 32208565
doi: 10.17458/per.vol17.2020.mps.type1diabetescomparison
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
210-219Informations de copyright
Copyright© of YS Medical Media ltd.